Characteristics of patients and use of ICS in the month following discharge from the ED
| No of visits(%) | Use of ICS(%) | |
|---|---|---|
| *In the month following discharge from the ED. | ||
| All ED visits | 6143 (100) | 63.0 |
| Sociodemographic factors | ||
| Age at ED visit (years) | ||
| 5–12 | 4340 (70.6) | 68.0 |
| 13–17 | 1803 (29.4) | 50.9 |
| Sex | ||
| Male | 3221 (52.4) | 64.6 |
| Female | 2922 (47.6) | 61.2 |
| Social assistance | ||
| Yes | 2996 (48.8) | 62.1 |
| No | 3147 (51.2) | 63.8 |
| Living on Montreal Island | ||
| Yes | 1950 (31.7) | 62.3 |
| No | 4193 (68.3) | 63.3 |
| Co-morbidity* | ||
| Yes | 929 (15.1) | 61.4 |
| No | 5214 (84.9) | 63.3 |
| Severity of the exacerbation | ||
| Consultation with a paediatrician or respiratory physician | ||
| Yes | 1495 (24.3) | 66.4 |
| No | 4648 (75.7) | 61.9 |
| Prescription of oral corticosteroids | ||
| Yes | 2499 (40.7) | 76.2 |
| No | 3644 (59.3) | 53.9 |
| Use of ICS in 6 months before ED visit | ||
| Yes | 2373 (38.6) | 79.4 |
| No | 3770 (61.3) | 52.6 |
| Markers of asthma severity and control 6 months before ED visit | ||
| Oral corticosteroids | ||
| Yes | 1471 (23.9) | 76.9 |
| No | 4672 (76.1) | 58.6 |
| Short acting β2 agonists | ||
| >10 doses per week | 4641 (75.5) | 77.1 |
| ⩽10 doses per week | 1502 (24.5) | 58.4 |
| Long acting β2 agonists | ||
| Yes | 67 (1.1) | 77.6 |
| No | 6076 (98.9) | 62.8 |
| Hospital admission for asthma | ||
| Yes | 337 (5.5) | 76.3 |
| No | 5806 (94.5) | 62.2 |
| ED visit for asthma | ||
| Yes | 1643 (26.7) | 67.9 |
| No | 4500 (73.3) | 61.2 |
| Medical visit to a paediatrician or a respiratory physician | ||
| Yes | 1861 (30.3) | 77.9 |
| No | 4282 (69.7) | 56.5 |